Abstract Objectives Anti-RNA polymerase III antibodies (ARA) are frequent in systemic sclerosis (SSc). However, the reported prevalence …
Abstract Objectives Anti-RNA polymerase III antibodies (ARA) are frequent in systemic sclerosis (SSc). However, the reported prevalence …
Abstract Objectives This study assessed how changes in lung function, skin fibrosis and digital ulceration (DU) burden predict …
Objective Systemic lupus erythematosus (SLE), a systemic autoimmune disease with heterogeneous severity, poses a challenge in …
Objective Antinuclear antibodies (ANA) are powerful biomarkers in systemic sclerosis (SSc). Functional antibodies (FA) might be …
Introduction Systemic sclerosis (SSc) is a rare autoimmune disease currently classified into two subgroups based on skin extension. The …
Abstract Objectives The objectives of this study were to compare fatigue in a large multinational SSc cohort with general population …
Abstract Objectives To compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and …
Abstract Objectives Patients with systemic sclerosis (SSc) are at increased risk for osteoporosis (OP) and associated fragility …
Abstract Objective The renin-angiotensin-aldosterone system (RAAS) and glucocorticoids (GCs) are involved in vascular remodeling and …
Abstract Objectives The specific roles of remission status, lupus low disease activity state (LLDAS), and damage accrual on the …
Purpose of review Systemic sclerosis (SSc) is a severe rheumatic disease characterized by a considerable heterogeneity in clinical …
Abstract Background Rituximab (RTX) is widely administered to patients with autoimmune disease (AID). This study aimed to estimate the …
Abstract Objective In patients with SSc, peripheral vasculopathy can promote critical ischaemia and gangrene. The aim of this study was …
Objective Pulmonary hypertension (PH) is a frequent and life‐limiting complication of systemic sclerosis (SSc). However, data on …